ClinicalTrials.Veeva

Menu

Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty

Rothman Institute Orthopaedics logo

Rothman Institute Orthopaedics

Status

Completed

Conditions

Osteoarthritis, Hip

Treatments

Drug: Multi-modal with one week of opioids offered
Drug: Standard of Care
Drug: Multi-modal with as needed opioids

Study type

Interventional

Funder types

Other

Identifiers

NCT03358888
2017- Chen

Details and patient eligibility

About

This is a prospective, three-arm, comparative study with a provider-crossover design. The first arm will comprise the standard of care pain regimen after discharge, which comprises PRN oxycodone, tramadol, and acetaminophen. The second arm will comprise a multimodal pain regimen; however, patients will still be routinely provided PRN oxycodone and tramadol to use on an as needed basis. The third arm will comprise a multimodal pain management protocol, which does not routinely allow for opioid consumption. However, patients will be provided a one week supply of oxycodone and tramadol for emergency pain relief only.

Enrollment

228 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients undergoing unilateral, primary cementless THA with underlying diagnosis of osteoarthritis.
  • ASA I - III
  • Spinal anesthesia
  • Male and Female over 18 who are willing and able to provide informed consent

Exclusion criteria

  • Opioid use within 3 months prior to surgery
  • General anesthesia
  • Non-english speaking
  • ASA IV or greater
  • Allergy/contraindications to protocol medications
  • Renal insufficiency with Cr > 2.0 or hepatic failure
  • Sensory/motor disorder involving the operative limb
  • Planned or unplanned discharge to rehab
  • Length of stay >3 days
  • Revision or conversion THA
  • Cigarette smokers

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

228 participants in 3 patient groups

Standard of Care
Active Comparator group
Treatment:
Drug: Standard of Care
Multi-modal with as needed opioids
Active Comparator group
Treatment:
Drug: Multi-modal with as needed opioids
Multi-modal with one week of opioids offered
Active Comparator group
Treatment:
Drug: Multi-modal with one week of opioids offered

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems